Elekta, SE0000163628

Elekta stock gained 1.31 percent ahead of the next report

Published on 10/08/2026 at 10:14 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Elekta stock generated SEK 3.54 billion in Q1 FY2026/27 revenue, down 3 percent year over year. Adjusted gross margin reached 42.6 percent on August 27, 2026.

Bauhaus-Poster mit geometrischen Formen und Schriftzug MEDTECH in kräftigen Farben
Geometrisches Bauhaus-Poster mit Sektor-Schriftzug MEDTECH visualisiert abstrakt das Geschäftsfeld von Elekta AB SE0000163628, Illustration mit AI erstellt.

Elekta stock (ISIN SE0000163628) was last at SEK 54.00 on Nasdaq Stockholm on October 7, 2026, at 4:26 p.m. CEST, up 1.31 percent from SEK 53.30. The next scheduled report is Q2 FY2026/27 on November 25, 2026, according to Elekta.

Margins improve despite lower revenue

Elekta's latest reported quarter covered May through July 2026. According to Stocksentinel, reported revenue fell 3 percent year over year to SEK 3.54 billion, from SEK 3.65 billion in Q1 FY2025/26.

The operational contrast was sharper than the revenue line. Adjusted gross margin increased to 42.6 percent from 37.0 percent, a gain of 5.6 percentage points, while adjusted EBIT rose 68 percent to SEK 395 million, according to Stocksentinel; the report also cited a SEK 53 million US tariff refund as a margin factor.

Guidance keeps the recovery test clear

Elekta reiterated fiscal 2026/27 guidance for constant-currency sales growth of 2 percent to 4 percent and an adjusted EBIT margin of 12.5 percent to 13.5 percent. The company also reported more than SEK 500 million in annualized savings from its operating model, as detailed by Stocksentinel.

For investors, the key question is whether the margin gains can offset slower Solutions revenue. Services revenue grew 4 percent on a reported basis to SEK 1.91 billion in the first quarter, while Solutions revenue fell 10 percent on a reported basis to SEK 1.63 billion, according to the same quarterly analysis.

Consensus target remains above the stock

Marketscreener lists a Hold mean consensus from 14 analysts, with an average target of SEK 59.69, a high target of SEK 100.00 and a low target of SEK 41.00. Against the October 7 price of SEK 54.00, the average target lies 10.5 percent above the stock.

The range shows why the consensus is not uniform. The low target is 24.1 percent below the October 7 price, while the high target is 85.2 percent above it, leaving execution of the Evo rollout, regional demand and order conversion as the central valuation variables.

Stock sits below its yearly high

Elekta's October 7 trading range was SEK 52.80 to SEK 54.35, with volume of 321,287 shares. The 52-week range was SEK 41.86 to SEK 66.70, placing the last price 19.0 percent below the yearly high and 29.0 percent above the yearly low.

The market is therefore pricing a recovery story with a visible operating improvement but a weaker top line. Elekta stock was last at SEK 54.00 on Nasdaq Stockholm on October 7, 2026, while the November 25 report date offers the next scheduled checkpoint.

Elekta stock key facts

  • Company: Elekta AB (publ)
  • ISIN: SE0000163628
  • Ticker: EKTA B.ST
  • Trading venue: Nasdaq Stockholm
  • Price (as of October 7, 2026, 4:26 p.m. CEST): SEK 54.00
  • 52-week range: SEK 41.86-66.70
  • Sector / Industry: Health Care / Medical Equipment

Upcoming dates for Elekta stock

  • November 25, 2026: Q2 FY2026/27 report
  • February 25, 2027: Q3 FY2026/27 report
  • May 27, 2027: Q4 FY2026/27 report

More news and analyses on Elekta stock

Disclaimer...

en | SE0000163628 | ELEKTA | boerse | 70264023 | bgmi